353 related articles for article (PubMed ID: 34162835)
21. Thiazole-based chalcones as potent antimicrobial agents. Synthesis and biological evaluation.
Liaras K; Geronikaki A; Glamočlija J; Cirić A; Soković M
Bioorg Med Chem; 2011 May; 19(10):3135-40. PubMed ID: 21524583
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial activity of carvacrol: current progress and future prospectives.
Nostro A; Papalia T
Recent Pat Antiinfect Drug Discov; 2012 Apr; 7(1):28-35. PubMed ID: 22044355
[TBL] [Abstract][Full Text] [Related]
23. Novel pyranopyrazole derivatives comprising a benzoxazole core as antimicrobial inhibitors: Design, synthesis, microbial resistance and machine aided results.
Reddy GM; Kumari AK; Reddy VH; Garcia JR
Bioorg Chem; 2020 Jul; 100():103908. PubMed ID: 32413632
[TBL] [Abstract][Full Text] [Related]
24. Lectins as antimicrobial agents.
Breitenbach Barroso Coelho LC; Marcelino Dos Santos Silva P; Felix de Oliveira W; de Moura MC; Viana Pontual E; Soares Gomes F; Guedes Paiva PM; Napoleão TH; Dos Santos Correia MT
J Appl Microbiol; 2018 Nov; 125(5):1238-1252. PubMed ID: 30053345
[TBL] [Abstract][Full Text] [Related]
25. Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019-June 2021).
Kariyawasam RM; Julien DA; Jelinski DC; Larose SL; Rennert-May E; Conly JM; Dingle TC; Chen JZ; Tyrrell GJ; Ronksley PE; Barkema HW
Antimicrob Resist Infect Control; 2022 Mar; 11(1):45. PubMed ID: 35255988
[TBL] [Abstract][Full Text] [Related]
26. Changes in antimicrobial resistance and outcomes of health care-associated infections.
Aydın M; Azak E; Bilgin H; Menekse S; Asan A; Mert HTE; Yulugkural Z; Altunal LN; Hatipoğlu ÇA; Tuncer Ertem G; Altunok ES; Demirkaya MH; Çeviker SA; Akgul F; Memis Z; Konya P; Azap A; Aydin G; Korkmaz D; Karakoç ZÇ; Yapar D; Karakecili F; Gunal O; Keske S; Kapmaz M; Kader C; Demirel A; Ergönül Ö
Eur J Clin Microbiol Infect Dis; 2021 Aug; 40(8):1737-1742. PubMed ID: 33586014
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial and antibiofilm activities of nanoemulsions containing Eucalyptus globulus oil against Pseudomonas aeruginosa and Candida spp.
Quatrin PM; Verdi CM; de Souza ME; de Godoi SN; Klein B; Gundel A; Wagner R; de Almeida Vaucher R; Ourique AF; Santos RCV
Microb Pathog; 2017 Nov; 112():230-242. PubMed ID: 28970174
[TBL] [Abstract][Full Text] [Related]
28. Nanomaterial-based treatments for medical device-associated infections.
Tran N; Tran PA
Chemphyschem; 2012 Jul; 13(10):2481-94. PubMed ID: 22517627
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of antimicrobial resistance among hospital-associated pathogens.
Khan A; Miller WR; Arias CA
Expert Rev Anti Infect Ther; 2018 Apr; 16(4):269-287. PubMed ID: 29617188
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of β-ionone derived chalcones as potent antimicrobial agents.
Sharma V; Singh G; Kaur H; Saxena AK; Ishar MP
Bioorg Med Chem Lett; 2012 Oct; 22(20):6343-6. PubMed ID: 22999415
[TBL] [Abstract][Full Text] [Related]
31. Peptides as the next generation of anti-infectives.
Mercer DK; O'Neil DA
Future Med Chem; 2013 Mar; 5(3):315-37. PubMed ID: 23464521
[TBL] [Abstract][Full Text] [Related]
32. Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections.
Makabenta JMV; Nabawy A; Li CH; Schmidt-Malan S; Patel R; Rotello VM
Nat Rev Microbiol; 2021 Jan; 19(1):23-36. PubMed ID: 32814862
[TBL] [Abstract][Full Text] [Related]
33. In vitro antimicrobial activity of ten medicinal plants against clinical isolates of oral cancer cases.
Panghal M; Kaushal V; Yadav JP
Ann Clin Microbiol Antimicrob; 2011 May; 10():21. PubMed ID: 21599889
[TBL] [Abstract][Full Text] [Related]
34. Biofilm formation mechanisms and targets for developing antibiofilm agents.
Rabin N; Zheng Y; Opoku-Temeng C; Du Y; Bonsu E; Sintim HO
Future Med Chem; 2015; 7(4):493-512. PubMed ID: 25875875
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of action and initial evaluation of a membrane active all-D-enantiomer antimicrobial peptidomimetic.
McGrath DM; Barbu EM; Driessen WH; Lasco TM; Tarrand JJ; Okhuysen PC; Kontoyiannis DP; Sidman RL; Pasqualini R; Arap W
Proc Natl Acad Sci U S A; 2013 Feb; 110(9):3477-82. PubMed ID: 23345420
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology and Resistance Patterns of Bacterial and Fungal Colonization of Biliary Plastic Stents: A Prospective Cohort Study.
Lübbert C; Wendt K; Feisthammel J; Moter A; Lippmann N; Busch T; Mössner J; Hoffmeister A; Rodloff AC
PLoS One; 2016; 11(5):e0155479. PubMed ID: 27171497
[TBL] [Abstract][Full Text] [Related]
37. Alternative antimicrobials: the properties of fatty acids and monoglycerides.
Churchward CP; Alany RG; Snyder LAS
Crit Rev Microbiol; 2018 Sep; 44(5):561-570. PubMed ID: 29733249
[TBL] [Abstract][Full Text] [Related]
38. Perspectives for clinical use of engineered human host defense antimicrobial peptides.
Pachón-Ibáñez ME; Smani Y; Pachón J; Sánchez-Céspedes J
FEMS Microbiol Rev; 2017 May; 41(3):323-342. PubMed ID: 28521337
[TBL] [Abstract][Full Text] [Related]
39. A review on antimicrobial botanicals, phytochemicals and natural resistance modifying agents from Apocynaceae family: Possible therapeutic approaches against multidrug resistance in pathogenic microorganisms.
Anand U; Nandy S; Mundhra A; Das N; Pandey DK; Dey A
Drug Resist Updat; 2020 Jul; 51():100695. PubMed ID: 32442892
[TBL] [Abstract][Full Text] [Related]
40. Brevinin-1GHd: a novel Hylarana guentheri skin secretion-derived Brevinin-1 type peptide with antimicrobial and anticancer therapeutic potential.
Jiang Y; Wu Y; Wang T; Chen X; Zhou M; Ma C; Xi X; Zhang Y; Chen T; Shaw C; Wang L
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32347293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
